Verenium Corporation today announced its first quarter earnings for 2009 reporting total revenues for the quarter ending March 31, 2009 at $14.4 million. Earnings are slightly down from first quarter 2008 when the Company reported $15.2 million in total revenues.
According to a company news release, President and Chief Executive Officer, Carlos A. Riva, commented on the company’s financials by saying, “We had a strong start to 2009, beginning with the announcement of our 50/50 joint venture with BP for developing commercial cellulosic ethanol facilities. This critical partnership firmly positions us, along with BP, to be a first mover in the field of next-generation ethanol. As we look toward commercial operations, we continue to be very encouraged by the political climate and support for alternative energy and, specifically, biofuels.
Verenium has had several big announcements in the past few months including the consolidation of the company’s R&D headquarters to Jennings, LA; announced the second phase of the BP partnership to develop cellulosic ethanol from non-food feedstocks, and announced Highlands County, Florida as the location for their first commercial cellulosic ethanol facility. In addition, launched a new enzyme for the food and beverage industry called Veretase. Visit www.verenium.com for more information about the Company’s financial report.